Actinogen Medical (ASX:ACW) has launched a buy-back of its ordinary fully paid shares under a new employee share scheme, according to a Thursday Australian bourse filing.
The company proposed to buy back a maximum of around 2.8 million of its ordinary shares, per the filing.
The buy-back is expected to commence on April 28, the filing added.
The company's shares fell 3% in recent Thursday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.